BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 3930325)

  • 1. Platelet function during continuous insulin infusion treatment in insulin-dependent diabetic patients.
    Mayfield RK; Halushka PV; Wohltmann HJ; Lopes-Virella M; Chambers JK; Loadholt CB; Colwell JA
    Diabetes; 1985 Nov; 34(11):1127-33. PubMed ID: 3930325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased platelet arachidonic acid metabolism in diabetes mellitus.
    Halushka PV; Mayfield R; Wohltmann HJ; Rogers RC; Goldberg AK; McCoy SA; Loadholt CB; Colwell JA
    Diabetes; 1981; 30(Suppl 2):44-8. PubMed ID: 6795072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Near-normal glycaemic control does not correct abnormal platelet reactivity in diabetes mellitus.
    Jackson CA; Greaves M; Boulton AJ; Ward JD; Preston FE
    Clin Sci (Lond); 1984 Nov; 67(5):551-5. PubMed ID: 6434224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of vitamin E supplementation on platelet thromboxane A2 production in type I diabetic patients. Double-blind crossover trial.
    Gisinger C; Jeremy J; Speiser P; Mikhailidis D; Dandona P; Schernthaner G
    Diabetes; 1988 Sep; 37(9):1260-4. PubMed ID: 3044891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased platelet thromboxane synthesis in diabetes mellitus.
    Halushka PV; Rogers RC; Loadholt CB; Colwell JA
    J Lab Clin Med; 1981 Jan; 97(1):87-96. PubMed ID: 7452084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased platelet prostaglandin and thromboxane synthesis in diabetes mellitus.
    Halushka PV; Rogers RC; Loadholt CB; Wohltman H; Mayfield R; McCoy S; Colwell JA
    Horm Metab Res Suppl; 1981; 11():7-11. PubMed ID: 7033097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of vitamin E administration on platelet function in diabetes mellitus.
    Kunisaki M; Umeda F; Inoguchi T; Watanabe J; Nawata H
    Diabetes Res; 1990 May; 14(1):37-42. PubMed ID: 2134664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship of insulin antibodies, platelet-fixing immune complexes and platelet-associated IgG to in vitro platelet aggregation and thromboxane B2 synthesis in childhood type 1 (insulin-dependent) diabetes mellitus.
    Triolo G; Davì G; Giardina E; Cardella F; Meli F; Strano A; Bompiani GD
    Diabetes Res; 1989 Jan; 10(1):1-5. PubMed ID: 2503285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet aggregation, platelet cAMP levels and thromboxane B2 synthesis in patients with diabetes mellitus.
    Chen SY; Yu BJ; Liang YQ; Lin WD
    Chin Med J (Engl); 1990 Apr; 103(4):312-8. PubMed ID: 2167823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of heparin on platelet aggregation and release and thromboxane A2 production.
    Mohammad SF; Anderson WH; Smith JB; Chuang HY; Mason RG
    Am J Pathol; 1981 Aug; 104(2):132-41. PubMed ID: 7258300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet aggregation in type 1 diabetes without microvascular disease during continuous subcutaneous insulin infusion.
    Turk Z; Flego I; Kerum G
    Horm Metab Res; 1996 Feb; 28(2):95-100. PubMed ID: 8867906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Behavior of intracellular glutathione during platelet thromboxane synthesis in diabetes.
    Thomas G; Lucas FV; Schumacher OP; Skrinska V
    Prostaglandins Leukot Med; 1986 Apr; 22(1):117-28. PubMed ID: 3459196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modification of platelet aggregation and thromboxane synthesis by intravascular contrast media.
    Paajanen H; Kormano M; Uotila P
    Invest Radiol; 1984; 19(4):333-7. PubMed ID: 6434489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of acrolein on human platelet aggregation.
    Selley ML; Bartlett MR; McGuiness JA; Ardlie NG
    Chem Biol Interact; 1990; 76(1):101-9. PubMed ID: 2118426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet glutathione and thromboxane synthesis in diabetes.
    Thomas G; Skrinska V; Lucas FV; Schumacher OP
    Diabetes; 1985 Oct; 34(10):951-4. PubMed ID: 3930319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid decrease of platelet aggregation (ADP--and collagen--induced) and of platelet circulating aggregates by the artificial pancreas in insulin-dependent diabetics.
    Coppola L; Misso L; Giugliano D; Torella R; Passariello N; Tirelli A
    Diabete Metab; 1984 Jan; 10(1):31-5. PubMed ID: 6724099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of thromboxane A2 synthesis in human platelets by coagulation factor Xa.
    Sinha AK; Rao AK; Willis J; Colman RW
    Proc Natl Acad Sci U S A; 1983 Oct; 80(19):6086-90. PubMed ID: 6577468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in thromboxane production between neonatal and adult platelets in response to arachidonic acid and epinephrine.
    Stuart MJ; Dusse J; Clark DA; Walenga RW
    Pediatr Res; 1984 Sep; 18(9):823-6. PubMed ID: 6435080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of inhibition of nitric oxide synthesis in the aggregation of platelets due to the stimulated production of thromboxane A2.
    Banerjee D; Mazumder S; Sinha AK
    Blood Coagul Fibrinolysis; 2014 Sep; 25(6):585-91. PubMed ID: 25083729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological characterization of cinnamophilin, a novel dual inhibitor of thromboxane synthase and thromboxane A2 receptor.
    Yu SM; Wu TS; Teng CM
    Br J Pharmacol; 1994 Mar; 111(3):906-12. PubMed ID: 8019768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.